Poul Sorensen

Researcher

Related Research

Multiple Cancers

The spatial metabolome hubble project to decipher tumour-driven immunosuppression (MetaboHUB)

What do a telescope capturing detailed pictures of space and a newly funded team of cancer researchers leading an innovative project on metabolites and our immune system have in common? ...
Read More
Rare Cancers

New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...
Read More
Pediatric & Young Adult Cancers

Precision oncology for young people (PROFYLE)

For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE, a pan-Canadian project to give children, adolesce...
Read More
Completed

Prostate Cancer

Targeting the adaptive molecular landscape in castrate-resistant prostate cancer

TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry ...
Read More
Completed

Rare Cancers

Genomics of forme fruste tumours: new vistas on cancer biology and treatment

Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...
Read More

Related News & Events

Research Highlight|October 30, 2024

Drug discovery could prevent spread of childhood bone cancer

A team of TFRI-funded researchers at the University of British Columbia identified a potential drug that could halt the spread of osteosarcoma.

Research Highlight|January 15, 2020

Goundbreaking discovery could help block metastasis for two kinds of sarcomas, including the one that claimed Terry Fox

TFRI researchers have found that a family of drugs known as Class 1 HDAC inhibitors can block sarcoma metastasis in mice by hindering a cancer cell’s ...

All News & Events